Multi-spectroscopic, voltammetric and molecular docking studies on binding of anti-diabetic drug rosigiltazone with DNA

被引：41
作者：
Ponkarpagam S. [1 ]
Mahalakshmi G. [1 ]
Vennila K.N. [1 ]
Elango K.P. [1 ]
机构：
[1] Department of Chemistry, Gandhigram Rural Institute (Deemed to be University), Gandhigram
来源：
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy | 2021年 / 234卷
关键词：
DNA; Drug interaction; Groove binding; Rosiglitazone; Voltammetry;
D O I：
10.1016/j.saa.2020.118268
中图分类号：
学科分类号：
摘要：
The binding of an anti-diabetic drug rosiglitazone (RG) with calf-thymus DNA (CT-DNA) in physiological buffer (pH 7.4) has been investigated using various spectral techniques such as UV–Vis, fluorescence, 1H NMR and circular dichroism (CD) coupled with viscosity measurement and molecular docking studies. The binding of RG with CT-DNA results in small hypochromism without any change in absorption maximum and fluorescence quenching with hardly any shifts in emission maximum suggesting groove binding mode of interaction. The binding constant is found to be 4.2 × 102 M−1 at 298 K. Thermodynamic analysis reveal that the binding is spontaneous and H-bonding and van der Waals forces play predominant role in the binding of RG with CT-DNA. Competitive interaction between RG and ethidium bromide with CT-DNA, viscosity measurements, KI quenching, 1H NMR and CD studies substantiate the prosed mode of binding. Voltammetric investigations suggest that the electro-reduction of RG is an adsorption controlled process and shift of reduction peak to more negative potential, with a binding constant of 3.4 × 103 M−1, validates the groove binding mode of interaction between RG and CT-DNA. Molecular docking reveals that RG binds in the minor groove of DNA and the dominating interaction forces are H-bonding and hydrophobic interactions. © 2020 Elsevier B.V.
引用
收藏
相关论文
共 33 条
[1]  
Wolffenbuttel B.H.R., Sels J.P., Huijberts M.S.P., Rosiglitazone, Expert. Opin. Pharmacother., 2, pp. 467-478, (2001)
[2]  
Wilson-Fritch L., Nicoloro S., Chouinard M., Lazar M.A., Chui P.C., Leszyk J., Straubhaar J., Czech M.P., Corvera S., Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone, J. Clin. Invest., 114, pp. 1281-1289, (2004)
[3]  
Kou S., Lou Y.Y., Zhou K.L., Wang B.L., Lin Z.Y., Shi J.H., In vitro exploration of interaction behavior between calf thymus DNA and fenhexamid with the help of multi-spectroscopic methods and molecular dynamics simulations, J. Mol. Liq., 296, (2019)
[4]  
Shi J.H., Zhou K.L., Lou Y.Y., Pan D.Q., Multi-spectroscopic and molecular docking studies on the interaction of darunavir, a HIV protease inhibitor with calf thymus DNA, Spectrochim. Acta A, 193, pp. 14-22, (2018)
[5]  
Shi J.H., Lou Y.Y., Zhou K.L., Pan D.Q., Probing the behavior of calf thymus DNA upon binding to a carboxamide fungicide boscalid: insights from spectroscopic and molecular docking approaches, J. Biomol. Struct. Dyn., 36, pp. 2738-2745, (2018)
[6]  
Shi J.H., Lou Y.Y., Zhou K.L., Pan D.Q., Exploration of intermolecular interaction of calf thymus DNA with sulfosulfuron using multi-spectroscopic and molecular docking techniques, Spectrochim. Acta A, 204, pp. 209-216, (2018)
[7]  
Dong X.M., Lou Y.Y., Zhou K.L., Shi J.H., Exploration of association of telmisartan with calf thymus DNA using a series of spectroscopic methodologies and theoretical calculation, J. Mol. Liq., 266, pp. 1-9, (2018)
[8]  
Sirajuddin M., Ali S., Badshah A., Drug-DNA interactions and their study by UV-Visible, fluorescence spectroscopies and cyclic voltammetry, J. Photochem. Photobiol. B, 124, pp. 1-19, (2013)
[9]  
Rehman S., Sarwar T., Husain M.A., Ishqi H.M., Tabish M., Studying non-covalent drug-DNA interactions, Arch. Biochem. Biophys., 576, pp. 49-60, (2015)
[10]  
Shi J.H., Pan D.Q., Jiang M., Liu T.T., Wang Q., In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multispectroscopic and molecular docking methods, J. Biomol. Struct. Dyn., 35, pp. 2211-2223, (2017)
1234